Hemovigilance and blood safety

Jain, Ashish; Kaur, Ravneet

doi:10.4103/0973-6247.98911

Cited by 32 publications

(25 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…5 Among the Asian countries, a well established hemovigilance system is lacking and there is paucity of data on hemovigilance except for Japan, which has published report on adverse transfusion reactions and infectious diseases. 6,7 Viral infections such as HIV, HBV and HCV cause big anxiety due to protracted viraemia along with carrier / latent state. Transfusion of blood components contribute up to 1% to the HIV transmission among the individuals in India.…”

Section: Antibodies Against Hepatitis C Virus (Anti Hcv) 4 Antibody mentioning

confidence: 99%

Seroprevalence of transfusion-transmissible infectious agents (HIV, HBV, HCV, plasmodium species and treponema pallidum infections) among blood donors at a Tertiary Care Teaching Hospital in Chennai: Changing trends over a period of five years

2020

IJMR

View full text Add to dashboard Cite

Section: Antibodies Against Hepatitis C Virus (Anti Hcv) 4 Antibody mentioning

confidence: 99%

Seroprevalence of transfusion-transmissible infectious agents (HIV, HBV, HCV, plasmodium species and treponema pallidum infections) among blood donors at a Tertiary Care Teaching Hospital in Chennai: Changing trends over a period of five years

2020

IJMR

View full text Add to dashboard Cite

“…The objective of IHN is to organize and maintain a body concerned with the safety of blood and its components, transfusion medicines and haemovigilance throughout the world. The IHN is working along with 'International society of blood transfusion' (ISBT) to ensure a better service 7 .…”

Section: Haemovigilance -Origin and Important Definitionsmentioning

confidence: 99%

Haemovigilance - Roles and Global Status in Transfusion Safety: A Review

Sreekumar¹,

Kumar²,

Sarathi³

et al. 2017

Int. Res. J. Pharm.

View full text Add to dashboard Cite

Blood transfusion plays a key role in improving health and saves many lives. Haemovigilance system is the programme which ensures the transfusion safety by monitoring every step of transfusion process from donor to recipient. This system mainly focused on collection and analysis of data concerned with adverse events/reactions related with transfusion of blood or its components with the aim of identifying their causes and outcomes and prevents their occurrence or recurrence. Thus the ultimate object of haemovigilance system is improving the quality and safety of transfusion therapy.

show abstract

“…Among the Asian counties a well established hemovigilance system is lacking and there is paucity of data on hemovigilance except in Japan. 18 In India, a national blood system has been launched on December10, 2012. 19 This programme is an integral part of Pharmacovigilance programme of India.…”

Section: 13mentioning

confidence: 99%

Donor Hemovigilance Programme in managing Blood Transfusion Needs: Complications of Whole Blood Donation

Mangwana¹

2013

J Pathol Nep

View full text Add to dashboard Cite

Background: Hemovigilance like quality systems and audits have become an integral part of Blood Transfusion Services in the developed countries and has contributed greatly to its development. Hemovigilance begins with donors and must enable the collection of information on reactions occurring during the donation of blood, selections of donors and to prevent such incidents. The aim of study was to help identify the trends of adverse events , occurring in blood donors at a tertiary-care hospital, to recommend best practices to improve donor care and safety Materials and Methods:This record-based study was conducted on all adverse events related to allogenic whole blood donations performed over 24 months. All whole blood donations were analyzed. All adverse events occurring during or at the end of the donation were noted using a standardized format and analyzed determining significance at p<0.05. Results:Overall rate was 0.3% with vasovagal reactions constituting 82%, and 18% mild syncopal reactions (p<0.001). Immediate vasovagal reaction with injury was very rare (0.007%). Vasovagal reactions showed a significant association with young age, female gender, first time donation status. Mean age of persons recording adverse effects was 30.23 ± 7.49 years as compared to those without adverse effects, 31.14 ± 8.56 years. Conclusion:Donor safety is an essential perquisite to increase voluntary blood donation. AE analysis helps in identifying the blood donors at risk of AE, applying appropriate motivational strategies, predonation counseling, care during and after donation, developing guidelines and hemovigilance programme in countries with limited resources.

show abstract

Hemovigilance and blood safety

Cited by 32 publications

References 5 publications

Seroprevalence of transfusion-transmissible infectious agents (HIV, HBV, HCV, plasmodium species and treponema pallidum infections) among blood donors at a Tertiary Care Teaching Hospital in Chennai: Changing trends over a period of five years

Seroprevalence of transfusion-transmissible infectious agents (HIV, HBV, HCV, plasmodium species and treponema pallidum infections) among blood donors at a Tertiary Care Teaching Hospital in Chennai: Changing trends over a period of five years

Haemovigilance - Roles and Global Status in Transfusion Safety: A Review

Donor Hemovigilance Programme in managing Blood Transfusion Needs: Complications of Whole Blood Donation

Contact Info

Product

Resources

About